| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | Apr 08, 2024 | Sale | $127.72 | 5,352 | 683,546 | 461,675 | Apr 10, 2024, 08:53 PM | |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | Apr 03, 2024 | Sale | $127.30 | 55,690 | 7,089,111 | 486,844 | Apr 05, 2024, 08:50 PM | |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | Apr 04, 2024 | Sale | $126.18 | 37,074 | 4,677,997 | 477,536 | Apr 05, 2024, 08:50 PM | |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | Apr 05, 2024 | Sale | $126.40 | 55,012 | 6,953,722 | 486,505 | Apr 05, 2024, 08:50 PM | |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Pres., R&D, and CMO | Jan 16, 2024 | Option Exercise | $243.92 | 1,546 | 377,100 | 15,001 | Jan 18, 2024, 01:46 PM | |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Taub Rebecca | Chief Medical Officer, EVP R&D | Jun 11, 2018 | Sale | $287.46 | 73,526 | 21,135,783 | 655,540 | Jun 12, 2018, 08:55 PM |
Menu